Specialty Generic Drugs Market

The specialty generic drugs market encompasses off-patent, complex medications like biosimilars and injectables that provide cost-effective alternatives to branded drugs. These products primarily serve patients with complex conditions such as cancer and autoimmune disorders, distributed through channels like specialty, retail, and hospital pharmacies. Key growth drivers include the patent expiration of high-cost branded drugs, increasing adoption of biosimilars, and widespread pressure to contain healthcare costs globally.